Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2011.12.21
关于对控股子公司进行增资的公告
2011.12.21
关于内部控制规则落实情况整改完成的公告
2011.12.21
第二届董事会第十次会议决议公告
2011.12.21
股票期权激励计划（草案）
2011.12.21
股票期权激励计划（草案）摘要
2011.12.21
北京市中伦律师事务所关于公司股权激励计划的法律意见书
2011.12.21
华英证券有限责任公司关于《深圳市白熊生物药业股份有限公司股票期权激励计划（草案）》之独...
2011.12.21
第二届监事会第九次会议决议公告
2011.12.21
股票期权激励计划激励对象名单
2011.12.20
停牌公告
第一页
上一页
139
140
141
142
143
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
